- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02343029
Physical Activity and Cerebral Metabolism in the Elderly: a Randomised Controlled Trial (SMART)
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Frankfurt am Main, Germany, 60487
- Department of Sports Medicine, Institute of Sports Sciences, Goethe University
-
Frankfurt am Main, Germany, 60590
- Institute of General Practice, Goethe University,
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- be above 65 years of age,
- voluntariness
- capacity to consent,
- having passed medical entry exam by the Department of Sports Medicine,
4) regular mental capacity, 5) written informed consent
Exclusion Criteria:
- untreated clotting disorders,
- musculoskeletal diseases significantly reducing mobility,
- severe bacterial or viral infections,
- severe respiratory diseases (Gold IV),
- acute pulmonary embolism,
- instable angina pectoris or severe heart failure (NYHA III or IV),
- severe vascular disease of the extremities or the brain,
- severe pulmonary-cardiac dysfunction,
- acute myocardial infarction or early phase of rehabilitation,
- critical aortal stenosis,
- severe hypertrophic and obstructive cardiomyopathy,
- untreated malignant arrhythmias,
- untreated severe hypertonia,
- severe pulmonary hypertonia,
- symptomatic cardiac malformations,
- cardiac-block grade II or III,
- left bundle branch block,
- complex ventricular arrhythmias,
- Cognitive impairment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
Participants in the Intervention group exercise three times a week for 30 minutes on a bicycle ergometer (optibike med, ergoline GmbH, Bitz, Germany) in the integrated gym hall of one of the participating residencies.
Training is individualised as respective performance is adapted to the power at the first ventilator threshold (assessed during cardiopulmonary exercise test).
|
During the first 4 weeks of intervention two of the three weekly training sessions are offered as group training supervised by the respective qualified exercise physiologist of the Department of Sports Medicine.
After 4 weeks, participants' physical performance is reassessed at the Department of Sports Medicine.
If necessary, workload is readjusted to achieve the initially defined exercise intensity.
|
Active Comparator: Waiting Control
Participants of Waiting Control continue their regular physical activity behaviour for 12 weeks.
They will start the same exercise intervention after a reassessment at week 12 for the next upcoming 12 weeks.
(13-24)
|
During the first 4 weeks of intervention two of the three weekly training sessions are offered as group training supervised by the respective qualified exercise physiologist of the Department of Sports Medicine.
After 4 weeks, participants' physical performance is reassessed at the Department of Sports Medicine.
If necessary, workload is readjusted to achieve the initially defined exercise intensity.
After waiting for 12 weeks with normal daily activity, patients are allocated to a individualised aerobic exercise training, too.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in cerebral metabolism (assessed by MRSI)
Time Frame: 6 month
|
assessed by MRSI, Primary hypothesis is that aerobic exercise leads to an increase of cerebral N-acetyl-aspartate (NAA; mediated by plasma neurotrophins). Secondary hypothesis stipulates an increase of markers of neuronal energy reserve: i.e. the ratio of phosphocreatinin to creatinine and of adenosine-tri-phosphate (ATP) to ~di-phosphate (ADP). Third hypothesis is an increase in the volume of cortical grey matter |
6 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cardiopulmonary exercise test (Aerobic exercise capacity is determined by a physician-supervised CPET)
Time Frame: 0, 3 and 6 month
|
Aerobic exercise capacity is determined by a physician-supervised CPET
|
0, 3 and 6 month
|
Psychometric testing 1 (verbal declarative memory [Verbal Learning and Memory test; adapted German version of the Rey Auditory Verbal Learning test]
Time Frame: 0, 3 and 6 month
|
verbal declarative memory [Verbal Learning and Memory test; adapted German version of the Rey Auditory Verbal Learning test]
|
0, 3 and 6 month
|
Psychometric testing 2 (frontal executive control [Colour-Word-Interference test; adapted German version of the Stroop test; Trail-Making-Test Part B]
Time Frame: 0, 3 and 6 month
|
frontal executive control [Colour-Word-Interference test; adapted German version of the Stroop test; Trail-Making-Test Part B]
|
0, 3 and 6 month
|
Psychometric testing 3 (working memory [Digit Span Test forward and backward]
Time Frame: 0, 3 and 6 month
|
working memory [Digit Span Test forward and backward]
|
0, 3 and 6 month
|
Psychometric testing 4 9semantic and phonematic fluency, nonverbal declarative memory and visual-constructive abilities by means of the CERAD-Plus (Consortium to Establish a Registry for Alzheimer's Disease) Neuropsychological Battery)
Time Frame: 0, 3 and 6 month
|
semantic and phonematic fluency, nonverbal declarative memory and visual-constructive abilities by means of the CERAD-Plus (Consortium to Establish a Registry for Alzheimer's Disease) Neuropsychological Battery
|
0, 3 and 6 month
|
Psychometric testing 5 (speed of cognitive processing is assessed by means of the Trail-Making-Test Part A)
Time Frame: 0, 3 and 6 month
|
speed of cognitive processing is assessed by means of the Trail-Making-Test Part A
|
0, 3 and 6 month
|
Psychometric testing 6 (depressive disorders: Geriatric Depression Scale)
Time Frame: 0, 3 and 6 month
|
depressive disorders: Geriatric Depression Scale
|
0, 3 and 6 month
|
Psychometric testing 7 (Age-associated subjective memory impairment is assessed using a memory complaint questionnaire [MAC-Q]
Time Frame: 0, 3 and 6 month
|
Age-associated subjective memory impairment is assessed using a memory complaint questionnaire [MAC-Q]
|
0, 3 and 6 month
|
Psychometric testing 8 (cristalline intelligence is assessed by means of a verbal intelligence test [Multiple-Choice Word Test: MWT-B]
Time Frame: 0, 3 and 6 month
|
cristalline intelligence is assessed by means of a verbal intelligence test [Multiple-Choice Word Test: MWT-B]
|
0, 3 and 6 month
|
Psychometric testing 9 (dementia and mild cognitive impairment using the Mini Mental State Examination and the Instrumental Activities of Daily Living Questionnaire)
Time Frame: 0, 3 and 6 month
|
dementia and mild cognitive impairment using the Mini Mental State Examination and the Instrumental Activities of Daily Living Questionnaire
|
0, 3 and 6 month
|
Balance and strength (postural sway (balance) and gait data acquisition via the capacitive force-measuring platform (30 Hz) WinFDM v0.0.41® (Zebris© GmbH, Isny, Germany)
Time Frame: 0, 3 and 6 month
|
postural sway (balance) and gait data acquisition via the capacitive force-measuring platform (30 Hz) WinFDM v0.0.41® (Zebris© GmbH, Isny, Germany)
|
0, 3 and 6 month
|
Pain Assessment (German Pain Questionnaire)
Time Frame: 0, 3 and 6 month
|
German Pain Questionnaire
|
0, 3 and 6 month
|
History of diet (Food frequency questionnaire DEGS1)
Time Frame: 0, 3 and 6 month
|
Food frequency questionnaire DEGS1
|
0, 3 and 6 month
|
History and fear of falling (German version of the Falls-Efficacy-Scale International Version)
Time Frame: 0, 3 and 6 month
|
German version of the Falls-Efficacy-Scale International Version
|
0, 3 and 6 month
|
Physical activity (International Physical Activity Questionnaire, Lifetime Total Physical Activity Questionnaire and Accelerometry)
Time Frame: 0, 3 and 6 month
|
International Physical Activity Questionnaire, Lifetime Total Physical Activity Questionnaire and Accelerometry
|
0, 3 and 6 month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Johannes Pantel, Prof., Institute of General Practice, Goethe University, Frankfurt/Main, Germany
- Principal Investigator: Winfried E Banzer, Prof., Department of Sports Medicine, Institute of Sports Sciences, Goethe University, Frankfurt/Main, Germany
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SMART
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Impairment
-
University of California, San FranciscoNational Institute on Aging (NIA)RecruitingMild Cognitive Impairment | Cognitive Decline | Cognitive Deterioration | Cognitive Impairment, Mild | Cognitive Deficits, MildUnited States
-
Stanford UniversityRecruitingMild Cognitive Impairment | Subjective Cognitive ImpairmentUnited States
-
Fondazione Don Carlo Gnocchi OnlusUniversity of Florence; Consorzio di Bioingeneria e Informatica Medica; Gutenberg...CompletedCognitive Dysfunction | Mild Cognitive Impairment | Vascular Cognitive ImpairmentItaly
-
University of California, Los AngelesCompletedMild Cognitive Impairment (MCI) | Age-associated Cognitive ImpairmentUnited States
-
Universidad de ZaragozaNot yet recruitingMild Cognitive Impairment | Randomized Controlled Trial | Subjective Cognitive Impairment
-
BaycrestCentre for Aging and Brain Health InnovationUnknownNeurocognitive Disorders | Cognitive Dysfunction | Mental Disorder | Cognitive Impairment, Mild | Cognitive Disorder | Nonamnestic Mild Cognitive ImpairmentCanada
-
Region SkaneLund University; Berry LabCompletedMemory Impairment | Cognitive Impairment, MildSweden
-
University of GeorgiaApplied Universal Dynamics, Corp.; Van Robotics, Inc.Active, not recruitingRobot-assisted Cognitive Training for Lonely Older Adults With Mild Cognitive Impairment (MCI) (MCI)Cognitive Change | Aging | Cognitive Impairment, MildUnited States
-
University Health Network, TorontoRecruiting
-
Wake Forest University Health SciencesActive, not recruiting
Clinical Trials on Individualised aerobic exercise training
-
Umeå UniversityRecruitingCongenital Heart Disease | Univentricular HeartSweden
-
UNC Lineberger Comprehensive Cancer CenterCompletedStem Cell Transplantation, HematopoieticUnited States
-
National Taiwan University HospitalCompletedAtrial FibrillationTaiwan
-
Riphah International UniversityCompletedSpinal Cord InjuriesPakistan
-
University of HoustonTerminated
-
Istanbul University - Cerrahpasa (IUC)CompletedObstructive Sleep Apnea SyndromeTurkey
-
University of Alberta, Physical EducationCanadian Breast Cancer Research AllianceCompleted
-
Chang Gung Memorial HospitalCompleted
-
Chang Gung Memorial HospitalUnknownStroke Patients With Cognitive DeclineTaiwan
-
Federal University of UberlandiaSuspendedHypertension | Dyslipidemias | Multimorbidity | Multiple Chronic ConditionsBrazil